Letter Sequence Other |
---|
EPID:L-2019-NEW-0004, Shine Medical Technologies, LLC Application for an Operating License (Approved, Closed) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance, Acceptance
- Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement
Results
Other: ML19235A308, ML19324F963, ML20057F950, ML20114E315, ML20126G523, ML20226A262, ML21029A103, ML21053A261, ML21089A228, ML21089A334, ML21096A250, ML21130A314, ML21145A060, ML21161A115, ML21209A997, ML21210A438, ML22042A018, ML22075A331, ML22075A336, ML22095A067, ML22124A073, ML22125A040, ML22152A108, ML22187A134, ML22206A208, ML22216A112, ML22220A261, ML22308A233, ML22322A212, ML22322A223, ML22347A177, ML22347A214, ML22348A067, ML22348A070, ML22348A072, ML23006A185
|
MONTHYEARML19211C0442019-07-17017 July 2019 Shine Medical Technologies, LLC Application for an Operating License Project stage: Request ML19211C1432019-07-17017 July 2019 Shine Medical Technologies, LLC Application for an Operating License Project stage: Request ML19235A3082019-09-0505 September 2019 Shine Medical Technologies, LLC - Cover Letter for Notice of Receipt and Availability of Operating License Application Project stage: Other ML19276D4112019-10-0808 October 2019 Shine Medical Technologies, LLC - Acceptance for Docketing Letter Project stage: Acceptance Review ML19276D4092019-10-0808 October 2019 Shine Medical Technologies, LLC - Operating License Application Acceptance Review Results Project stage: Request ML19276D4102019-10-0808 October 2019 Shine Medical Technologies, LLC - Acceptance for Docketing Federal Register Notice Project stage: Acceptance Review ML19337A2752019-11-14014 November 2019 Shine Medical Technologies, LLC Supplement 1 to Final Safety Analysis Report Project stage: Request ML19353C6872019-12-19019 December 2019 Environmental Site Audit Regarding Shine Medical Technologies, LLC - Proposed Medical Isotope Production Facility Project stage: Request ML19324F9622020-01-0202 January 2020, 6 January 2020 Shine Medical Technologies, LLC - Notice of Opportunity for Hearing and Petition for Leave to Intervene Project stage: Request ML19324F9632020-01-0202 January 2020 Shine Medical Technologies, LLC - Cover Letter for Notice of Opportunity for Hearing and Petition for Leave to Intervene Project stage: Other ML20057F9502020-03-0606 March 2020 Shine Medical Technologies, LLC - Instrumentation and Control Regulatory Audit Plan Project stage: Other ML20105A2952020-03-27027 March 2020 Shine Medical Technologies, LLC, Supplement 2 to License Application, Rev.2 to Final Safety Analysis Report Project stage: Supplement ML20114E3152020-04-30030 April 2020 Shine Medical Technologies, LLC - Operating License Application Technical Review Schedule Project stage: Other ML20126G5232020-05-0707 May 2020 Shine Medical Technologies, LLC - Regulatory Audit Plan Related to Electrical Power Systems Project stage: Other ML20226A2622020-08-14014 August 2020 Shine Medical Technologies, LLC - Accident Analysis and Criticality Safety Audit Plan Project stage: Other ML20255A0272020-08-28028 August 2020 Shine Medical Technologies, LLC Operating License Application Response to Request for Additional Information and Supplement No. 3 Project stage: Supplement ML21309A0192020-10-16016 October 2020 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 2, 3, and 8 Project stage: RAI ML20311A1242020-10-30030 October 2020 Shine Medical Technologies, LLC, Operating License Application Supplement No. 4 Submittal of a Revision to the Shine Physical Security Plan Project stage: Supplement ML21309A0232020-11-10010 November 2020 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 6 and 13 Project stage: RAI ML20325A0262020-11-13013 November 2020 Submittal of a Mark-Up to the Draft NRG-Proposed SHINE-Specific Security Measures Project stage: Request ML20357A0862020-12-10010 December 2020 Enclosure 1 - Final Safety Analysis Report Change Summary Project stage: Request ML21011A2242020-12-15015 December 2020 Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information Project stage: Supplement ML20352A2252020-12-18018 December 2020 Shine Environmental RAIs - Cumulative Impacts Project stage: RAI ML21309A0442021-01-27027 January 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 9 and 11 Project stage: RAI ML21019A1592021-01-27027 January 2021 Public Meeting Summary January 12 2021 Project stage: Meeting ML21029A1032021-01-29029 January 2021 Enclosure 1 - Response to Final Safety Analysis Report Chapters 2, 3, and 8 Requests for Additional Information Project stage: Other ML21029A1022021-01-29029 January 2021 Shine Medical Technologies, LLC Operating License Application Response to Request for Additional Information Project stage: Response to RAI ML21029A0382021-01-29029 January 2021 Request for Exemption from Criticality Accident Alarm System Monitoring Requirements for the Shine Irradiation Unit Cells and Material Staging Building Project stage: Request ML21057A0052021-02-26026 February 2021 Shine Medical Technologies. LLC Application for an Operating License Commitment Change Related to the Submission of a Revision to the Technical Specifications Project stage: Request ML21053A2612021-03-11011 March 2021 Shine Medical Technologies - Geotechnical Audit Plan Project stage: Other ML21075A0122021-03-16016 March 2021 Shine Medical Technologies, LLC - Application for an Operating License, Revision 1 of Shine Response to Request for Additional Information 2.4-1 Project stage: Response to RAI ML21095A2142021-03-23023 March 2021 Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 6, Engineered Safety Features Project stage: Request ML21095A2222021-03-23023 March 2021 Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 5, Cooling Systems Project stage: Request ML21095A2292021-03-23023 March 2021 Shine Medical Technologies, LLC, Response to Request for Additional Information and Supplement No. 7 Project stage: Supplement ML21095A2352021-03-23023 March 2021 Shine Medical Technologies, LLC, Cover Letter for Response to Request Tor Additional Information and Supplement No. 7 Project stage: Supplement ML21089A3342021-04-0707 April 2021 Shine Medical Technologies, LLC - Summary of Audit Related to Geotechnical Topics Project stage: Other ML21089A0012021-04-0808 April 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Meteorological Data, Cooling Systems, and Physical Security Project stage: RAI ML21096A2502021-04-0808 April 2021 Shine Medical Technologies - Fire Protection Audit Plan Project stage: Other ML21106A1362021-04-16016 April 2021 Shine Medical Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Request for Additional Information 3.4-6 Project stage: Response to RAI ML21089A2282021-04-21021 April 2021 Shine Medical Technologies, LLC - Physical Security Plan Audit Summary Project stage: Other ML21130A3132021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Topics Enclosure 2 Project stage: Request ML21130A3142021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Plan Project stage: Other ML21145A0602021-06-0202 June 2021 Shine Medical Technologies - Ch 6 8 13 and Exemption RAI Project stage: Other ML21161A1162021-06-10010 June 2021 Shine Medical Technologies, LLC - Cyber Security Audit Plan W/ 2 Encl Project stage: Request ML21161A1152021-06-10010 June 2021 Shine Medical Tech Ltr - Cyber Security Audit Plan Enclosure 1 Project stage: Other ML21162A3182021-07-0101 July 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Fire Protection Project stage: RAI ML21172A1952021-07-0101 July 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Instrumentation and Control Systems Project stage: RAI ML21208A1352021-07-27027 July 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information Project stage: Response to RAI ML21209A9972021-08-0303 August 2021 Shine Medical Technologies, LLC - Update to Operating License Application Technical Review Schedule Project stage: Other ML21210A4382021-08-13013 August 2021 Shine Medical Technologies, LLC - Cyber Security RAI Project stage: Other 2020-08-14
[Table View] |
|
---|
Category:Audit Plan
MONTHYEARML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22216A1122022-08-0808 August 2022 Shine Technologies LLC - Regulatory Audit Plan of Logic Lifecycle Described in Operating License ML22152A1082022-06-0606 June 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Tech Specs ML22094A1142022-05-23023 May 2022 Shine Medical Technologies LLC - Draft Regulatory Audit Plan for Phased Approach Session 2 ML22095A0672022-04-0606 April 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for I&C Session 3 ML22042A0182022-02-15015 February 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for I&C ML21161A1252021-06-10010 June 2021 Shine Cyber Security Audit Topics _ Enclosure 2 ML21161A1152021-06-10010 June 2021 Shine Medical Tech Ltr - Cyber Security Audit Plan Enclosure 1 ML21137A3392021-05-24024 May 2021 Shine Medical Technologies - Hfe Audit Plan Letter ML21130A3142021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Plan ML21096A2502021-04-0808 April 2021 Shine Medical Technologies - Fire Protection Audit Plan ML21096A2492021-04-0808 April 2021 Shine Medical Technologies - Fire Protection Audit Topics (V2) ML21053A2612021-03-11011 March 2021 Shine Medical Technologies - Geotechnical Audit Plan ML20226A2622020-08-14014 August 2020 Shine Medical Technologies, LLC - Accident Analysis and Criticality Safety Audit Plan ML20126G5232020-05-0707 May 2020 Shine Medical Technologies, LLC - Regulatory Audit Plan Related to Electrical Power Systems ML20126G5242020-05-0707 May 2020 Shine Medical Technologies, LLC - Regulatory Audit Topics Related to Electrical Power Systems ML20057F9502020-03-0606 March 2020 Shine Medical Technologies, LLC - Instrumentation and Control Regulatory Audit Plan ML20057F9522020-03-0606 March 2020 Shine Medical Technologies, LLC - Instrumentation and Control Regulatory Audit Questions ML19353C7152019-12-19019 December 2019 Enclosure 2 - Environmental Site Audit Needs List ML19353C7192019-12-19019 December 2019 Enclosure 3 - Draft Environmental Site Audit Schedule ML19353C7202019-12-19019 December 2019 Enclosure 1 - Shine Medical Technologies, LLC Environmental Audit Plan ML13168A5622013-07-0303 July 2013 Environmental Site Audit Regarding Sine Medical Inc. Proposed Radioisotope Production Facility 2022-08-08
[Table view] Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] |
Text
February 15, 2022 Dr. Gregory Piefer, Chief Executive Officer SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, LLC REGULATORY AUDIT OF INSTRUMENTATION AND CONTROL SYSTEMS DESCRIBED IN OPERATING LICENSE APPLICATION (EPID NO. L-2019-NEW-0004)
Dear Dr. Piefer:
The NRC staff has prepared an audit plan related to the review of Chapter 7, Instrumentation and Control Systems, of the SHINE operating license application. The enclosed audit plan provides the regulatory basis for the audit, describes the scope of the audit, identifies the audit team, and provides a listing of audit questions.
The audit will be conducted virtually and is intended to close gaps identified during the technical review. As such, the audit will be held on February 15, 2022, from 4:00pm to 5:00pm.
Additional audit sessions may be scheduled to support the continued review of the operating license application.
Following completion of the audit, the NRC staff will provide an audit summary. The summary will include a description of any information identified during the audit that will need to be docketed to supplement the application and allow the NRC staff to continue its review.
If you have any questions, please contact me at (301) 415-1217, or by electronic mail at Joshua.Borromeo@nrc.gov.
Sincerely,
/RA Joshua Borromeo, Chief Non-Power Production and Utilization Facility Licensing Branch Division of Advanced Reactors and Non-Power Production and Utilization Facilities Office of Nuclear Reactor Regulation Docket No. 50-608 Construction Permit No. CPMIF-001
Enclosure:
Audit Plan cc: See next page
SHINE Medical Technologies, LLC Docket No. 50-608 cc:
Jeff Bartelme Licensing Manager SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545 Nathan Schleifer General Counsel SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545 Christopher Landers Director, Office of Conversion National Nuclear Security Administration, NA 23 U.S. Department of Energy 1000 Independence Avenue, SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept. of Materials Science and Engineering University of Maryland 4418 Stadium Drive College Park, MD 20742-2115 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548
ML22042A018 *electronic NRR-106 OFFICE NRR/DANU/PM NRR/DANU/BC NAME HCruz* JBorromeo*
DATE 2/3/2022 2/11/2022 OFFICE OF NUCLEAR REACTOR REGULATION REGULATORY AUDIT PLAN REGARDING CHAPTER 7, INSTRUMENTATION AND CONTROL SYSTEMS OPERATING LICENSE APPLICATION SHINE MEDICAL TECHNOLOGIES, LLC DOCKET NO. 50-608
Background
The U.S. Nuclear Regulatory Commission (NRC) staff is continuing its review of the SHINE Medical Technologies, LLC (SHINE) operating license application, submitted by letter dated July 17, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19211C044), in addition to Chapter 7, Instrumentation and Control Systems, of the SHINE final safety analysis report (FSAR) and responses to requests for additional information (RAI). This regulatory audit is intended to close technical gaps identified during the review of Chapter 7, as communicated periodically to SHINE in a Chapter 7 status tracker and documented in this plan.
Regulatory Audit Bases The licensees proposed instrumentation and control systems is being reviewed in accordance with the applicable regulatory requirements of Title 10 of the Code of Federal Regulations Part 50, Domestic Licensing of Production and Utilization Facilities. and applicable guidance provided in NUREG-1537, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Part 1, Format and Content, and Part 2, Standard Review Plan and Acceptance Criteria, (ADAMS Accession Nos. ML042430055 and ML042430048, respectively).
Regulatory Scope The scope of this audit addresses updates to the SHINE FSAR and associated responses to RAIs on the Highly Integrated Protection System (HIPS), Target Solution Vessel (TSV)
Reactivity Protection System (TRPS), Engineered Safety Feature Actuation System (ESFAS).
Consistent with the regulatory basis specified in the system RAIs, this information will supplement the licensing review to understand and confirm how TRPS and ESFAS: (1) will perform its safety function including after a single failure and meeting requirements for environmental qualification, redundancy, diversity, and independence; (2) will have surveillance tests and intervals that give confidence that the equipment will reliably perform its safety function; and (3) has appropriate digital hardware and software verification and validation programs to provide confidence in design quality. The audit may also address additional information and FSAR revisions provided for other systems, such as the Process Integrated Control System (PICS). Therefore, any additional information identified from the audit that is needed to address a regulatory finding may also be documented in the audit report.
Desired Outcomes for the Audit The desired outcomes of the audit are to: (1) gain a better understanding of information underlying the application in the area of instrumentation and control systems, (2) identify specific information that will require docketing to support the basis of the licensing or regulatory decision; and (3) close open technical items or identify a closure path in the Audit Topics and Questions section of this audit plan.
Information and Material necessary for the Regulatory Audit SHINE will need to provide design documentation, as noted below, in the electronic reading room to support the audit, to resolve open technical items. The staff anticipates SHINE identifying additional documents that may address open technical items.
- ESFAS and TRPS Design Documents (e.g., as referenced in response to RAI 7-10)
Audit Team The NRC staff participating in this audit will be:
- Jesse Seymour (NRR/DRO) - Human Factors Audit Team Logistics The virtual audit will be held on February 15, 2022, from 4:00pm to 5:00pm. This audit session will address the topics and questions as identified below. Should an additional audit session be needed, it will be scheduled accordingly. Additional audit sessions may be planned in advance, as new open technical items are identified, to support the understanding of information necessary to facilitate the continued review of the operating license application.
Deliverables At the completion of the regulatory audit, NRC staff will prepare a regulatory audit report, which will be issued within 60 days after the audit. New audit plans (including distinct entrance and exit discussions) will be issued as new open technical items are identified. Closure paths for each item will be captured in the Audit Topics and Questions section of this audit plan.
Audit Session: February 15, 2022, from 4:00pm to 5:00pm.
SECTION Open Items Closure Path & Information Needs (RCI Response, Supplement, Updated FSAR, etc.)
7.2 Design of Instrumentation and Control Systems 7.2.5 HIPS Design 7.2.5.1 HIPS Description
- Hard-Wired Module Open Technical Item 7.2.5-01 (HWM)
FSAR states, All TRPS components have self-testing capabilities, except the discrete APL of EIM which is functionally tested. Where in the FSAR or TS is periodic testing of HWMs discussed?
Please point where this is described in FSAR, or otherwise supplement the FSAR and TS to accurately reflect HWM testing (RAI).
- Equipment Interface Open Technical Item 7.2.5-02 Module (EIM)
FSAR, TRPS SSD, and ESFAS SSD state, All TRPS components have self-testing capabilities, except the discrete APL of EIM which is functionally tested. Figure 4-2, Overlap of Testing for the TRPS Platform and Figure 4-3, Overlap of Testing for the ESFAS Platform both show EIM High Drive Output being self-tested. These documents are inconsistent with the response to RAI 7-10.
Please explain this apparent inconsistency to staff and then update the FSAR to accurately reflect the use and crediting of self-testing capabilities (RAI).
- HIPS Module LEDs Open Technical Item 7.2.5-03 In response to the following statements:
- The ACTIVE LED will turn Red on a vital fault or when the module has one latch open
- The FAULT LED will never flash and not turn Red
- The FAULT LED will turn Yellow for any fault (non-vital or vital)
What color are these ACTIVE and FAULT LEDs during normal operations with no fault present? Please provide revised Tables 8-3 and 8-4 of the HIPS TR based on the SHINE design (RCI/RAI).
SECTION Open Items Closure Path & Information Needs (RCI Response, Supplement, Updated FSAR, etc.)
7.4 Target Solution Vessel Reactivity Protection System 7.4.2 TRPS Design Criteria 7.4.2.1.3 Protection System Open Technical Item 7.4.2-06 Reliability and Testability It is not clear how the 1/1 logic in Table 7.4.-1 meets the stated criteria above (i.e., no single failure results in loss of the protection function,).
Audit discussion on the trip logic of this function and how it addresses single failure.
Open Technical Item 7.4.2-07 The IF and TRPS has different operating modes and HIPS provides two modes in which an instrument channel can be removed from service: (1) it can be placed in trip, or (2) it can be placed in bypass (i.e., not tripped). It is not clear how the trip logic described in Table 7.4-1 meets single failure during operations concurrent with the instrument channel being removed from service during operation as inferred by the Technical Specifications and some narratives.
Staff is evaluating Single Failure analysis in electronic reading room.
Audit discussion to walk staff through Table 7.4-1 to explain how single failure is maintained with respect to stated trip logic when a channel is removed from service in bypass mode.
Open Technical Item Figure 7.4-1, TRPS Logic Diagrams (Sheet 7 of 14), indicates that in some cases both instrument channels and both actuation divisions A & B must be operable for the depicted functions to be performed. However, this contradicts NRC conventional definition of single failure, as provided in SDC15 (failure of one channel and ability to continue to provide intended monitoring and actuation functions).
Audit discussion to walk staff through Sheet 7 of 14 to explain operation of these channels and how single failure is achieved.
SECTION Open Items Closure Path & Information Needs (RCI Response, Supplement, Updated FSAR, etc.)
Open Technical Item 7.4.2-09 SHINE design criterion 15 requires inservice testability. The SE on the HIPS topical report states: The self-test capability of the discrete input circuit switch is evaluated by performing an open contact test and a closed contact test. In the TRPS some discrete inputs from the process (i.e., not just the trip/bypass switched) come into the system via the HWM and not the SFM. It is not clear how these inputs are readily testable Describe how these circuits are readily testable.
7.4.2.1.4 Protection System Open Technical Item 7.4.2-10 Independence FSAR Section 7.4.2.1.4 was revised to no longer credit manual means as the diverse method for actuation of the safety functions - therefore, the NRC no longer need to understand what process variables are used by the operators to decide when to initiate the safety functions by manual means.
It appears automatic diversity of the system will be solely credited in the FSAR. However, FSAR Section 7.4.5.2.4, Diversity was simultaneously revised to state: in each instance where a potential digital CCF could cause a failure to initiate protective actions, there exists either an alternate automatic means of mitigating events or an alternate means for the operator to identify, initiate, and assess protective actions. The FSAR contains an apparent contradiction of how the system partially addresses the fundamental design principle of diversity.
The staff accepts and prefers the use of manual diversity (that can be reasonably accomplished in needed timeframes) to address any limitation in design or functional diversity. However, such credit needs to be supported by a methodical assessment (e.g., D3 assessment).
Explain whether this is a contradiction in the FSAR and whether the existing D3 assessment credits manual operator action.